Not Medicare Enrolled

Dr. Lina Shah, M.D.

Neurology with Special Qualifications in Child Neurology Physician · Plano, TX
4032 MCDERMOTT RD, Plano, TX 75024
9727699000
Registered in NPPES since 2008
NPI: 1619153343 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Shah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shah? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Shah

Dr. Lina Shah is a neurology with special qualifications in child neurology physician in Plano, TX, with 18 years of NPI registration.

Between the years covered by Open Payments, Dr. Shah received a total of $7,141 from 51 pharmaceutical and/or device companies across 347 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Shah is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years of NPI registration $7,141 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$7,141
Total received (2018-2024)
Avg $1,020/year across 7 years
Top 20% in TX for neurology with special qualifications in child neurology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
347
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$476
2023
$435
2022
$1,001
2021
$880
2020
$1,674
2019
$1,182
2018
$1,492

Payments by company (2024)

Corium, LLC
$128
Neurelis, Inc.
$93
Azurity Pharmaceuticals, Inc.
$67
JAZZ PHARMACEUTICALS INC.
$55
ACADIA Pharmaceuticals Inc
$54
AQUESTIVE THERAPEUTICS, INC.
$18
Noven Therapeutics, LLC
$17
HARMONY BIOSCIENCES LLC
$16
IRONSHORE PHARMACEUTICALS INC.
$14
UCB, Inc.
$14
Top 3 companies account for 60.6% of 2024 payments
All-time payments by company (2018-2024) ›
LivaNova USA, Inc.
$1,396
Supernus Pharmaceuticals, Inc.
$838
Sunovion Pharmaceuticals Inc.
$651
UCB, Inc.
$488
Ironshore Pharmaceuticals Inc.
$374
Neurelis, Inc.
$293
Tris Pharma Inc
$244
Zogenix Inc.
$231
Corium, LLC
$226
Eisai Inc.
$165
Shire North American Group Inc
$164
Neos Therapeutics, LP
$154
SK Life Science, Inc.
$148
Greenwich Biosciences, Inc.
$145
Takeda Pharmaceuticals U.S.A., Inc.
$139
EISAI INC.
$132
Upsher-Smith Laboratories LLC
$112
JAZZ PHARMACEUTICALS INC.
$96
Rhodes Pharmaceuticals L.P.
$79
AQUESTIVE THERAPEUTICS, INC.
$68
Azurity Pharmaceuticals, Inc.
$67
Aprecia Pharmaceuticals, LLC
$59
Lundbeck LLC
$57
Allergan Inc.
$56
ACADIA Pharmaceuticals Inc
$54
Adlon Therapeutics L.P.
$53
Travere Therapeutics, Inc.
$52
GENZYME CORPORATION
$50
ARBOR PHARMACEUTICALS, INC.
$49
Sumitomo Pharma America, Inc.
$42
Biogen, Inc.
$39
Biohaven Pharmaceutical Holding Company Ltd.
$39
Noven Therapeutics, LLC
$38
NEUROPACE, INC.
$33
HARMONY BIOSCIENCES LLC
$31
Arbor Pharmaceuticals, Inc.
$28
Validus Pharmaceuticals LLC
$28
Marinus Pharmaceuticals, Inc.
$28
AbbVie Inc.
$26
Alexion Pharmaceuticals, Inc.
$17
Mallinckrodt Enterprises LLC
$17
Mirum Pharmaceuticals, Inc.
$17
Jazz Pharmaceuticals Inc.
$16
Catalyst Pharmaceuticals, Inc.
$15
PFIZER INC.
$14
IRONSHORE PHARMACEUTICALS INC.
$14
BioMarin Pharmaceutical Inc.
$14
Philips Electronics North America Corporation
$14
Cranial Technologies, Inc
$14
NATUS MEDICAL INCORPORATED
$12
Retrophin, Inc.
$10
Top 3 companies account for 40.4% of all-time payments
Associated products mentioned in payments ›
(820) Cholbam · ACTHAR · ADHANSIA XR · APTIOM · AZSTARYS · Adzenys XR-ODT · Aptensio XR · Azstarys · BOTOX · Briviact · COTEMPLA XR-ODT · Cholbam · Cotempla XR-ODT · DAYBUE · Doc Band · Dyanavel XR · EPIDIOLEX · Epidiolex · Equetro · Evekeo · Evekeo ODT · FYCOMPA · Fintepla · Fycompa · Healthcare Incubator · Horizant · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LIBERVANT · MYDAYIS · NURTEC ODT · Nayzilam · ONFI · OXTELLAR XR · POMPE - DISEASE · QELBREE · QUDEXY XR Topiramate Extended Release Capsules · QUILLIVANT XR · Quillichew ER · Quillivant XR · RNS System · SPINRAZA · SYMPAZAN · Spritam · TROKENDI XR · VALTOCO · VIGADRONE (VIGABATRIN) FOR ORAL SOLUTION · VNS - Sentiva · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VYVANSE · Vimizim · Vimpat · WAKIX · Wakix · XYREM · Xelstrym · ZONISADE · ZTALMY
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a neurology with special qualifications in child neurology physician in Plano?
Compare neurology with special qualifications in child neurology physicians in the Plano area by procedure volume, costs, and industry payment transparency.
Browse neurology with special qualifications in child neurology physicians nearby

Geographic Context

Neurology with special qualifications in child neurology physicians in nearby ZIP areas
34
County median income
$117,588
Nearest hospital to ZIP centroid (approximate)
CHILDRENS MEDICAL CENTER PLANO
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Shah is a neurology with special qualifications in child neurology physician, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Shah receive payments from pharmaceutical companies?
Yes. Dr. Shah received a total of $7,141 from 51 companies across 347 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Shah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →